Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will participate in t ...

Dynavax Technologies (NASDAQ:DVAX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday. A number ...

MURFREESBORO, TN / ACCESS Newswire / February 25, 2025 / National Health Investors, Inc. announced today that it will pay its first quarter dividend of $0.90 per common share on May 2, 2025 to ...

William Blair analyst Matt Phipps maintained a Hold rating on Kezar Life Sciences (KZR – Research Report) today. The company’s shares closed ...

Former UK Prime Minister Rishi Sunak has joined Prostate Cancer Research as an ambassador for the charity's campaign to ...

Lilly recently revised its revenue forecast for 2024 after seeing weaker-than-expected growth for Zepbound and diabetes brand ...